Men with multiple sclerosis (MS) who started on high-efficacy disease-modifying therapies (DMTs) experienced significantly ...

Columnist Desiree Lama, a lifelong Texan, struggles with the region's extreme heat, which can cause her MS symptoms to flare ...

A rising incidence of MS diagnosed among older adults in a Sicilian province has been evident since 2005, particularly for ...

For someone like me, who is retired and has three preteen children, the days surrounding Christmas and New Year’s feel like a liminal space. With no school or job to be at and no real schedule to keep ...

Immutep said IMP761 was found safe in initial data from a Phase 1 trial, with no treatment-related adverse events reported.

Exercise effectively eases fatigue and improves muscular fitness in MS patients, but the best type differs for each outcome, ...

About four in five adults with long-term stable MS who stopped first-line treatment with a DMT showed signs of disease ...

Columnist Ahna Crum knows what MS has taken from her, but she also recognizes the significant gifts it's granted over the ...

Tolebrutinib, expected to soon be submitted for U.S. approval for nonrelapsing SPMS, was granted the FDA's breakthrough ...

Columnist Desiree Lama has been living with MS for several years, yet she still appreciatea the advice and advocacy of her ...

Two studies linked a type of lesions with chronic inflammation, paramagnetic rim lesions, with worse MS disability ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...